Dexmedetomidine for LISA Procedure in Preterm Infants
Status:
Not yet recruiting
Trial end date:
2023-04-01
Target enrollment:
Participant gender:
Summary
The investigators aim to evaluate: the effectiveness of dexmedetomidine for analgesia and
sedation during LISA procedure, without compromising the respiratory drive; the safety of
this drug on the preterm infant in a pilot study.